Moitessier N

References (8)

Title : Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-alpha for different indications - Plescia_2022_Eur.J.Med.Chem_240_114543
Author(s) : Plescia J , Hedou D , Pousse ME , Labarre A , Dufresne C , Mittermaier A , Moitessier N
Ref : Eur Journal of Medicinal Chemistry , 240 :114543 , 2022
Abstract :
PubMedSearch : Plescia_2022_Eur.J.Med.Chem_240_114543
PubMedID: 35797897
Gene_locus related to this paper: human-FAP , human-PREP

Title : Discovery of covalent prolyl oligopeptidase boronic ester inhibitors - Plescia_2020_Eur.J.Med.Chem_185_111783
Author(s) : Plescia J , Dufresne C , Janmamode N , Wahba AS , Mittermaier AK , Moitessier N
Ref : Eur Journal of Medicinal Chemistry , 185 :111783 , 2020
Abstract :
PubMedSearch : Plescia_2020_Eur.J.Med.Chem_185_111783
PubMedID: 31732257
Gene_locus related to this paper: human-PREP

Title : Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein alpha - Plescia_2019_J.Med.Chem_62_7874
Author(s) : Plescia J , De Cesco S , Patrascu MB , Kurian J , Di Trani J , Dufresne C , Wahba AS , Janmamode N , Mittermaier AK , Moitessier N
Ref : Journal of Medicinal Chemistry , 62 :7874 , 2019
Abstract :
PubMedSearch : Plescia_2019_J.Med.Chem_62_7874
PubMedID: 31393718

Title : 3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors - Mariaule_2016_J.Med.Chem_59_4221
Author(s) : Mariaule G , De Cesco S , Airaghi F , Kurian J , Schiavini P , Rocheleau S , Huskic I , Auclair K , Mittermaier A , Moitessier N
Ref : Journal of Medicinal Chemistry , 59 :4221 , 2016
Abstract :
PubMedSearch : Mariaule_2016_J.Med.Chem_59_4221
PubMedID: 26619267
Gene_locus related to this paper: human-PREP

Title : Metabolic Instability of Cyanothiazolidine-Based Prolyl Oligopeptidase Inhibitors: a Structural Assignment Challenge and Potential Medicinal Chemistry Implications - Schiavini_2015_ChemMedChem_10_1174
Author(s) : Schiavini P , Pottel J , Moitessier N , Auclair K
Ref : ChemMedChem , 10 :1174 , 2015
Abstract :
PubMedSearch : Schiavini_2015_ChemMedChem_10_1174
PubMedID: 26018317

Title : Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells - De Cesco_2012_J.Med.Chem_55_6306
Author(s) : De Cesco S , Deslandes S , Therrien E , Levan D , Cueto M , Schmidt R , Cantin LD , Mittermaier A , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 55 :6306 , 2012
Abstract :
PubMedSearch : De Cesco_2012_J.Med.Chem_55_6306
PubMedID: 22765237

Title : Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors -
Author(s) : Lawandi J , Gerber-Lemaire S , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 53 :3423 , 2010
PubMedID: 20058865

Title : Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors - Lawandi_2009_J.Med.Chem_52_6672
Author(s) : Lawandi J , Toumieux S , Seyer V , Campbell P , Thielges S , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 52 :6672 , 2009
Abstract :
PubMedSearch : Lawandi_2009_J.Med.Chem_52_6672
PubMedID: 19888757